Spots Global Cancer Trial Database for EAGLE Trial CADDIE Artificial Intelligence Endoscopy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: EAGLE Trial CADDIE Artificial Intelligence Endoscopy
Official Title: Evaluation of Artificial Intelligence for Detection of Gastrointestinal Lesions in Endoscopy (EAGLE)
Study ID: NCT05730192
Interventions
Study Description
Brief Summary: The EAGLE study is a prospective randomized controlled multicenter parallel design trial, for the assessment of clinical performance of the CADDIE device and to confirm that the device performs as expected.
Detailed Description: The EAGLE study will be conducted with a parallel design. Patients who meet the study inclusion/exclusion criteria will be randomized in a 1:1 ratio to receive either computer-aided colonoscopy (CADDIE Arm) using CADDIE or standard colonoscopy without CADe (Control Arm). All resected polyps will be submitted for histologic examination.
Eligibility
Minimum Age: 40 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Israeli-Georgian Medical Research Clinic Healthycore, Tbilisi, , Georgia
Sana Klinikum Lichtenberg, Berlin, , Germany
Humanitas Mater Domini, Castellanza, Varese, Italy
Humanitas Catania, Catania, , Italy
Humanitas Research Hospital, Milan, , Italy
H-T. Centrum Medyczne, Tychy, , Poland
The Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, , Poland
Przychodnia Polskiej Fundacji Gastroenterologii, Warsaw, , Poland
University Hospital "Clinico Lozano Blesa" of Zaragoza, Zaragoza, , Spain
University College Hospital London, London, , United Kingdom
Contact Details
Name: Alessandro Repici, Prof.
Affiliation: Humanitas Research Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
